Renin-Angiotensin system blockers and cardiovascular death in kidney recipients.
暂无分享,去创建一个
[1] J. Chapman,et al. Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. , 2014, Transplantation.
[2] G. Opelz,et al. Cardiovascular Death in Kidney Recipients Treated With Renin–Angiotensin System Blockers , 2013, Transplantation.
[3] James M Robins,et al. Randomized Trials Analyzed as Observational Studies , 2013, Annals of Internal Medicine.
[4] M. Zeier,et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. , 2006, Journal of the American Society of Nephrology : JASN.
[5] G. Heinze,et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.